Related references
Note: Only part of the references are listed.Oncogenic AURKA-enhanced N6-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells
Fei Peng et al.
CELL RESEARCH (2021)
High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA
Duolan Naren et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells
Sarah Huff et al.
ACS CHEMICAL BIOLOGY (2021)
MEK inhibitors for the treatment of non-small cell lung cancer
Jing Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis
Marjon E. A. Wormgoor et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability
Pengpeng Zhu et al.
ONCOGENE (2021)
Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19
Loubna Mazini et al.
STEM CELL RESEARCH & THERAPY (2021)
The evolving landscape of N6-methyladenosine modification in the tumor microenvironment
Yunru Gu et al.
MOLECULAR THERAPY (2021)
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Eliza Yankova et al.
NATURE (2021)
FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
Sebastien Relier et al.
NATURE COMMUNICATIONS (2021)
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+CD25+Foxp3+regulatory T cells in the immune microenvironment
Alessandro Granito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers
Martina Mang Leng Lei et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Regulatory roles of RNA modifications in breast cancer
Kanchan Kumari et al.
NAR CANCER (2021)
A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
Weiqi Hong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1
Irina A. Elcheva et al.
LEUKEMIA (2020)
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
Omprakash Shriwas et al.
APOPTOSIS (2020)
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB
Sasithorn Wanna-udom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line
Alessio Malacrida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
Xiaoge Hu et al.
CELL DEATH AND DIFFERENTIATION (2020)
m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
Bo Tang et al.
MOLECULAR CANCER (2020)
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells
Jiexin Li et al.
CELLS (2020)
Acquired Resistance to Immune Checkpoint Inhibitors
Adam J. Schoenfeld et al.
CANCER CELL (2020)
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang et al.
CANCER CELL (2020)
RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia
Chao Shen et al.
CELL STEM CELL (2020)
SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer
Subhadra Kumari et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2020)
The Emerging Roles of RNA Modifications in Glioblastoma
Zhen Dong et al.
CANCERS (2020)
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation
Chuanzhao Zhang et al.
ONCOGENE (2020)
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su et al.
CANCER CELL (2020)
FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma
Li Xiao et al.
CANCER RESEARCH (2020)
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
Na Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma
Jingchao Wei et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate
Ya Xu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives
Zhijie Xu et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li et al.
DRUG RESISTANCE UPDATES (2020)
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Elisabeth Perez-Ruiz et al.
DRUG RESISTANCE UPDATES (2020)
RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
Chang Gu et al.
INNOVATION (2020)
N6-methyladenosine (m6A)RNAmodification in cancer stem cells
Zhonghua Ma et al.
STEM CELLS (2020)
Emerging Mechanisms by which EMT Programs Control Stemness
Molly M. Wilson et al.
TRENDS IN CANCER (2020)
An N6-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells
Mohammad B. Uddin et al.
BIOCHEMICAL PHARMACOLOGY (2019)
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
Li Zhong et al.
CANCER LETTERS (2019)
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Dali Han et al.
NATURE (2019)
Discovery of Small Molecules that Activate RNA Methylation through Cooperative Binding to the METTL3-14-WTAP Complex Active Site
Simona Selberg et al.
CELL REPORTS (2019)
N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling
Abhirami Visvanathan et al.
GENES (2019)
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Yue Huang et al.
CANCER CELL (2019)
YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma
Yang Bai et al.
FRONTIERS IN ONCOLOGY (2019)
The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA
Yihan Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
Katelyn Melgar et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment
Yuanming Cheng et al.
CELL REPORTS (2019)
N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
Huan Jin et al.
EBIOMEDICINE (2019)
Integrated analysis of transcriptome-wide m6A methylome of osteosarcoma stem cells enriched by chemotherapy
Yongjie Wang et al.
EPIGENOMICS (2019)
Pharmacological Inhibition of the RNA m6a Writer METTL3 As a Novel Therapeutic Strategy for Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
BLOOD (2019)
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
Kamal Chamoun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner
Simon Mueller et al.
NUCLEIC ACIDS RESEARCH (2019)
Double-slit photoelectron interference in strong-field ionization of the neon dimer
Maksim Kunitski et al.
NATURE COMMUNICATIONS (2019)
MODOMICS: a database of RNA modification pathways. 2017 update
Pietro Boccaletto et al.
NUCLEIC ACIDS RESEARCH (2018)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
m6A mRNA methylation sustains Treg suppressive functions
Jiyu Tong et al.
CELL RESEARCH (2018)
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification
Hengyou Weng et al.
CELL STEM CELL (2018)
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting -catenin through mRNA demethylation
Shun Zhou et al.
MOLECULAR CARCINOGENESIS (2018)
Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal
Jing Wen et al.
MOLECULAR CELL (2018)
Recognition of RNA N6- methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huilin Huang et al.
NATURE CELL BIOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function
Yuzhang Du et al.
NUCLEIC ACIDS RESEARCH (2018)
Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion
Zhenrui Li et al.
CELL RESEARCH (2018)
The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency
Alessandro Bertero et al.
NATURE (2018)
Cross-talk among writers, readers, and erasers of m(6)A regulates cancer growth and progression
Subbarayalu Panneerdoss et al.
SCIENCE ADVANCES (2018)
RNA modifications modulate gene expression during development
Michaela Frye et al.
SCIENCE (2018)
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Ly P. Vu et al.
NATURE MEDICINE (2017)
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Atul Bhardwaj et al.
NATURE COMMUNICATIONS (2017)
Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer
Yujiro Nishizawa et al.
Oncotarget (2017)
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Qi Cui et al.
CELL REPORTS (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program
Sicong Zhang et al.
CANCER CELL (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor
Huimin Lu et al.
CANCER RESEARCH (2016)
WTAP Expression Predicts Poor Prognosis in Malignant Glioma Patients
Zhuo Xi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
Chuanzhao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells
M. Drachsler et al.
CELL DEATH & DISEASE (2016)
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217-and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
Chuanzhao Zhang et al.
ONCOTARGET (2016)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
Coordination of m6A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming
Francesca Aguilo et al.
CELL STEM CELL (2015)
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Laetitia Seguin et al.
TRENDS IN CELL BIOLOGY (2015)
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype
S. M. Kessler et al.
CELL DEATH & DISEASE (2015)
De novo assembly of bacterial transcriptomes from RNA-seq data
Brian Tjaden
GENOME BIOLOGY (2015)
Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5
Yue Huang et al.
NUCLEIC ACIDS RESEARCH (2015)
Synthesis of a FTO Inhibitor with Anticonvulsant Activity
Guanqun Zheng et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is an Important Protumorigenic Factor in Hepatocellular Carcinoma
Tony Gutschner et al.
HEPATOLOGY (2014)
The splicing factor hnRNP C regulates expression of co-stimulatory molecules CD80 and CD40 in dendritic cells
Rong Jia et al.
IMMUNOLOGY LETTERS (2013)
Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells
D. Katoh et al.
ONCOGENESIS (2013)
Expression and roles of Wilms' tumor 1-associating protein in glioblastoma
Du-Il Jin et al.
CANCER SCIENCE (2012)
Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer
Qiao Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
Judit Anido et al.
CANCER CELL (2010)
Integrin ανβ6 acts as a prognostic indicator in gastric carcinoma
Z. -Y. Zhang et al.
CLINICAL ONCOLOGY (2008)
Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma
RC Bates et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Expression of alpha v integrin family in gastric carcinomas: Increased alpha v beta 6 is associated with lymph node metastasis
A Kawashima et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
Share Paper
